INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC., GENENTECH, INC., REPARE THERAPEUTICS INC. FILES APPLICATION FOR "USE OF ATR INHIBITORS IN COMBINATION WITH RADIOLIGAND THERAPY FOR THE TREATMENT OF CANCER"

GENEVA, Dec. 17 -- F. HOFFMANN-LA ROCHE AG (Grenzacherstrasse 1244070 Basel), HOFFMANN-LA ROCHE INC. (150 Clove Road, Overlook at Great Notch, Suite 8Little Falls, NJ 07424), GENENTECH, INC. (1 DNA WaySouth San Francisco, CA 94080-4990), REPARE THERAPEUTICS INC. (7171 Frederick-Banting, Building 2St-Laurent, Quebec H4S 1Z9) filed a patent application (PCT/US2025/032276) for "USE OF ATR INHIBITORS IN COMBINATION WITH RADIOLIGAND THERAPY FOR THE TREATMENT OF CANCER" on Jun 04, 2025. With publication no. WO/2025/255237, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual ...